Dopamine D3 receptors and salt-dependent hypertension

Abstract

Alterations in the dopaminergic system may contribute to the pathogenesis of hypertension. Dopamine D3 receptors have been shown to be involved in the regulation of sodium balance and hemodynamics in rodents. For determining the role of D3 receptors in salt-dependent hypertension, clearance experiments were performed in anesthetized salt-sensitive (DS) and salt-resistant (DR) Dahl rats that were fed a standard diet with either normal (0.2%) or high (4%) sodium content for 21 to 26 d, which induced hypertension in DS but not in DR rats. The D3 receptor agonist R(+)-7-hydroxy-dipropyl-aminotetralin (7-OH-DPAT) increased GFR by up to 35% and urinary sodium excretion by up to 4.4-fold in DR rats that were on both normal and high-sodium diet. 7-OH-DPAT-induced natriuresis also was observed in DS rats that were on normal diet but not in hypertensive DS rats that were on high-salt diet. No GFR response to 7-OH-DPAT was found in DS rats, irrespective of sodium diet. The diminished functional response to D3 receptor stimulation in DS rats was associated with a significantly lower [3H]-7-OH-DPAT binding to renal membrane protein when comparing DS with DR rats. Consequently, DR rats were treated with BSF 135170, a novel, highly selective D3 receptor antagonist, for 29 d. Whereas no change in systolic BP was observed during normal diet, high sodium intake significantly increased BP by almost 40 mmHg. In summary, both expression and function of the renal dopamine D3 receptor are impaired in salt-sensitive Dahl rats. Together with the induction of salt-dependent hypertension in genetically salt-resistant Dahl rats by D3 receptor blockade, the data strongly suggest that the deficiency in dopamine D3 receptors represents an important pathophysiological factor in the development of salt-dependent hypertension.